![]() | Up a level |
(2021) Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients. Journal of Cellular Physiology. pp. 5325-5338. ISSN 0021-9541
(2021) Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2. Life Sciences. p. 11. ISSN 0024-3205